Class II
Terminated
Auryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., One Marina Park Drive, 12th Floor, Boston, MA 02210, NDC 59922-631-01
This recall has been terminated (originally issued December 30, 2020).
- Recall Initiated
- December 9, 2020
- Posted
- December 30, 2020
- Recall Number
- D-0170-2021
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 2,170 bottles
- Firm Location
- Cambridge, MA, United States
- Official Source
- View on FDA website ↗
Reason for Recall
CGMP Deviations
Distribution
The product was distributed by two major distributors who further distributed the product nationwide and one specialty pharmacy.
Lot / Code Info
Lot Number: 9062, exp. date Feb 2021
More recalls by Akebia Therapeutics Dba Keryx Biopharmaceutials, Inc
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026